← Eichor
Condition: Acute Myeloid Leukemia In Children Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acute Myeloid Leukemia In Children

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus H
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07366801Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA · 3 location(s) · University Hospital, Tours · NCT05792007Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Phase N/A · 5 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06131801The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
NA · 1 location(s) · Ege University · NCT07203742Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling,
Phase N/A · 28 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05772559CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients
Phase 3 · 1 location(s) · Princess Maxima Center for Pediatric Oncology · NCT05994690The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia T
Phase 1/Phase 2 · 183 location(s) · PedAL BCU, LLC · NCT04726241A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After
Phase 1 · 8 location(s) · National Cancer Institute (NCI) · NCT07012044Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · 90 location(s) · PedAL BCU, LLC · NCT05183035Venetoclax Basket Trial for High Risk Hematologic Malignancies
Phase 1 · 5 location(s) · Andrew E. Place, MD · NCT05292664Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Maligna
Phase 4 · 1 location(s) · Gadjah Mada University · NCT07016165Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Phase 2 · 13 location(s) · Children's Hospital of Soochow University · NCT06221683Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractor
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT02390752Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Phase 2 · 1 location(s) · Princess Maxima Center for Pediatric Oncology · NCT06262438Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT07566377Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Phase 3 · 17 location(s) · Vastra Gotaland Region · NCT05477589A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT06810583Gut Health in Children With Cancer
Phase N/A · 1 location(s) · Great Ormond Street Hospital for Children NHS Foundation Tru · NCT06899581Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Phase 3 · 28 location(s) · Children's Oncology Group · NCT07022678Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04644016
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.